189 related articles for article (PubMed ID: 37513926)
1. Synthesis and Structure Determination of Substituted Thiazole Derivatives as EGFR/BRAF
Al-Wahaibi LH; El-Sheref EM; Hassan AA; Bräse S; Nieger M; Youssif BGM; Ibrahim MAA; Tawfeek HN
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513926
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAF
Alshammari MB; Aly AA; Youssif BGM; Bräse S; Ahmad A; Brown AB; Ibrahim MAA; Mohamed AH
Front Chem; 2022; 10():1076383. PubMed ID: 36578355
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-
Al-Wahaibi LH; Mohammed AF; Abdelrahman MH; Trembleau L; Youssif BGM
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770936
[TBL] [Abstract][Full Text] [Related]
4. Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAF
Gomaa HAM; Shaker ME; Alzarea SI; Hendawy OM; Mohamed FAM; Gouda AM; Ali AT; Morcoss MM; Abdelrahman MH; Trembleau L; Youssif BGM
Bioorg Chem; 2022 Mar; 120():105616. PubMed ID: 35078049
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAF
El-Kalyoubi SA; Gomaa HAM; Abdelhafez EMN; Ramadan M; Agili F; Youssif BGM
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242499
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF
Abou-Zied HA; Beshr EAM; Gomaa HAM; Mostafa YA; Youssif BGM; Hayallah AM; Abdel-Aziz M
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200464. PubMed ID: 36526595
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAF
Al-Wahaibi LH; Gouda AM; Abou-Ghadir OF; Salem OIA; Ali AT; Farghaly HS; Abdelrahman MH; Trembleau L; Abdu-Allah HHM; Youssif BGM
Bioorg Chem; 2020 Nov; 104():104260. PubMed ID: 32920363
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis-Pyrazoline Derivatives as Dual EGFR/BRAF
Al-Wahaibi LH; Abou-Zied HA; Beshr EAM; Youssif BGM; Hayallah AM; Abdel-Aziz M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240450
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents.
Al-Wahaibi LH; Mohammed AF; Abdelrahman MH; Trembleau L; Youssif BGM
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513950
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl)quinolin-2(1
El-Sheref EM; Bräse S; Tawfeek HN; Alasmary FA; Youssif BGM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686105
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAF
Al-Wahaibi LH; Abou-Zied HA; Hisham M; Beshr EAM; Youssif BGM; Bräse S; Hayallah AM; Abdel-Aziz M
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764362
[TBL] [Abstract][Full Text] [Related]
12. Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAF
Al-Wahaibi LH; Hisham M; Abou-Zied HA; Hassan HA; Youssif BGM; Bräse S; Hayallah AM; Abdel-Aziz M
Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004388
[TBL] [Abstract][Full Text] [Related]
13. Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies.
Youssif BGM; Morcoss MM; Bräse S; Abdel-Aziz M; Abdel-Rahman HM; Abou El-Ella DA; Abdelhafez ESMN
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257358
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Antiproliferative Potential of Thiazole and 4-Thiazolidinone Containing Motifs as Dual Inhibitors of EGFR and BRAF
Hassan AA; Mohamed NK; Aly AA; Ramadan M; Gomaa HAM; Abdel-Aziz AT; Youssif BGM; Bräse S; Fuhr O
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138441
[TBL] [Abstract][Full Text] [Related]
15. One-Pot Synthesis of 1-Thia-4-azaspiro[4.4/5]alkan-3-ones via Schiff Base: Design, Synthesis, and Apoptotic Antiproliferative Properties of Dual EGFR/BRAF
Al-Wahaibi LH; El-Sheref EM; Hammouda MM; Youssif BGM
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986566
[TBL] [Abstract][Full Text] [Related]
16. Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking.
Hassan RA; Hamed MIA; Abdou AM; El-Dash Y
Bioorg Chem; 2022 Aug; 125():105861. PubMed ID: 35569190
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of bis-thiohydantoin derivatives as an antiproliferative agents targeting EGFR inhibitory pathway.
Hassan AA; Aly AA; Ramadan M; Mohamed NK; Youssif BGM; Gomaa HAM; Bräse S; Nieger M; El-Aal ASA
Mol Divers; 2023 Jun; ():. PubMed ID: 37306891
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, DFT Analyses, Antiproliferative Activity, and Molecular Docking Studies of Curcumin Analogues.
Ahsan MJ; Choudhary K; Ali A; Ali A; Azam F; Almalki AH; Santali EY; Bakht MA; Tahir A; Salahuddin
Plants (Basel); 2022 Oct; 11(21):. PubMed ID: 36365289
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular modeling and biological evaluation of new benzo[4,5]thieno[3,2-b]pyran derivatives as topoisomerase I-DNA binary complex poisons.
Ahmed EM; Khalil NA; Zaher AF; Alhamaky SM; El-Zoghbi MS
Bioorg Chem; 2021 Jul; 112():104915. PubMed ID: 33905973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
